We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Buys

Rank Stock Value
1
RMD icon
ResMed
RMD
+$52.9M
2
WST icon
West Pharmaceutical
WST
+$39.7M
3
AMED
Amedisys
AMED
+$36.8M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$34M
5
SPOT icon
Spotify
SPOT
+$34M

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVR icon
151
Evercore
EVR
$12.4B
$27.5M 0.21%
466,825
+54,150
+13% +$2.95M
GH icon
152
Guardant Health
GH
$21.5B
$27.2M 0.21%
335,487
– –
CSCO icon
153
Cisco
CSCO
$457B
$26.9M 0.21%
576,820
-27,076
-4% -$1.19M
EVRI
154
DELISTED
Everi Holdings
EVRI
$26.8M 0.21%
5,198,400
+481,738
+10% +$2.45M
EVOP
155
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$25.7M 0.2%
1,124,737
– –
VZ icon
156
Verizon
VZ
$195B
$25.6M 0.2%
463,731
-21,137
-4% -$1.19M
KLAC icon
157
KLA
KLAC
$239B
$25.4M 0.2%
1,305,250
-416,750
-24% -$7.12M
KSU
158
DELISTED
Kansas City Southern
KSU
$25.2M 0.19%
168,925
-8,700
-5% -$1.22M
EXP icon
159
Eagle Materials
EXP
$6.29B
$25.2M 0.19%
358,550
-24,575
-6% -$1.55M
KURA icon
160
Kura Oncology
KURA
$800M
$24.5M 0.19%
1,502,217
– –
MNTA
161
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$24.4M 0.19%
+734,683
New +$23.4M
GRMN
162
Garmin
GRMN
$56.7B
$24.1M 0.19%
247,030
+109,330
+79% +$9.35M
JBLU icon
163
JetBlue
JBLU
$2.28B
$23.9M 0.18%
2,194,625
+586,525
+36% +$5.78M
MRK icon
164
Merck
MRK
$322B
$23.7M 0.18%
321,107
-5,073
-2% -$382K
QTWO icon
165
Q2 Holdings
QTWO
$3.8B
$23.6M 0.18%
275,000
– –
THR
166
DELISTED
Thermon Group Holdings
THR
$23.6M 0.18%
1,616,313
– –
RHI icon
167
Robert Half
RHI
$3.87B
$23.4M 0.18%
443,425
-34,550
-7% -$1.64M
FANG icon
168
Diamondback Energy
FANG
$57.1B
$23.3M 0.18%
557,151
– –
MCD icon
169
McDonald's
MCD
$192B
$23.3M 0.18%
126,280
+10,554
+9% +$1.94M
OGS icon
170
ONE Gas
OGS
$4.87B
$23.3M 0.18%
302,091
-59,725
-17% -$4.83M
BC icon
171
Brunswick
BC
$5.13B
$23.2M 0.18%
362,425
+53,175
+17% +$2.65M
EBS icon
172
Emergent Biosolutions
EBS
$373M
$23.2M 0.18%
+293,226
New +$21.9M
MRTX
173
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$22.8M 0.18%
199,814
– –
EGP icon
174
EastGroup Properties
EGP
$11.2B
$22.5M 0.17%
189,801
+34,385
+22% +$3.8M
ATO icon
175
Atmos Energy
ATO
$28.8B
$22.5M 0.17%
226,024
-22,500
-9% -$2.27M
5 6
7
8 9

Similar funds

GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.